Aptose Biosciences (APTO)

Aptose Biosciences (APTO) Cash flow


Aptose Biosciences Cash Flow

APTO's free cash flow for Q4 2022 was $-8.65M. For the 2022 fiscal year, APTO's free cash flow was decreased by $11.17M and operating cash flow was $-8.65M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -32.32M$ -32.32M$ -43.30M$ -33.89M$ -21.56M$ -23.21M
Investing Cash Flow
$ 30.07M$ 30.07M$ -35.21M$ 12.63M$ -17.37M$ 12.00K
Financing Cash Flow
$ 116.00K$ 116.00K$ 226.00K$ 58.81M$ 103.45M$ 27.87M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 141.99M$ 36.97M$ 39.11M$ 117.39M$ 79.84M$ 15.30M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
Issuance Of Capital Stock
$ 101.00K$ 101.00K$ 36.00K$ 58.40M$ 93.17M$ 25.72M
Issuance Of Debt
Repayment Of Debt
Free Cash Flow
$ -32.35M$ -32.35M$ -43.52M$ -33.97M$ -21.66M$ -23.54M
Domestic Sales
Foreign Sales
Currency in USD

Aptose Biosciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis